Skip to main content
Home
Latest news
Browse topics
Cardiovascular disorders
Chronic kidney disease
Diabetes devices & technology
GLP-1 receptor agonists
Hyperglycemia
Hypoglycemia
Obesity, diet, & lifestyle interventions
SGLT2 inhibitors
Type 1 diabetes
Type 2 diabetes
Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring
Fasting for religion and health in people with diabetes
The challenge of type 2 diabetes in children
HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved
Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice
The SURPASS trials: Summarizing efficacy data on tirzepatide
Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials
Why psychosocial care matters
DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022
The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH

Type 2 diabetes


Browse the latest news, expert commentary, and educational content on type 2 diabetes.


Highlights

07-03-2023 | Type 2 diabetes | News

‘Substantial’ bodyweight reductions with tirzepatide in people with type 2 diabetes and obesity

SURMOUNT-2 trial results show bodyweight reductions with tirzepatide that rival those seen with other approved anti-obesity medications in people with type 2 diabetes.

04-05-2023 | Gestational diabetes | News

Mild gestational glucose intolerance tied to future type 2 diabetes risk

Impaired glucose tolerance during pregnancy that does not meet the criteria for gestational diabetes nevertheless increases the likelihood that women will later develop type 2 diabetes, a study shows.

03-03-2023 | Healthcare systems | News

Health informatics system aids timely, equitable diabetes care

A health informatics system based on routine clinical data helps physicians to prioritize high-risk people with diabetes, deliver more equitable care, and manage healthcare capacity, report researchers.

More on type 2 diabetes

09-25-2023 | Gestational diabetes | News

Gestational diabetes independently linked to increased future mortality risk

09-20-2023 | Latent autoimmune diabetes of adulthood | News

Latent autoimmune diabetes carries mortality and CVD risks comparable to type 2 diabetes

09-15-2023 | Type 2 diabetes | News

Young-onset type 2 diabetes diagnosis linked to shortened life expectancy

09-04-2023 | Type 2 diabetes | News

New model predicts kidney disease progression risk in type 2 diabetes

08-31-2023 | Type 2 diabetes | News

Pragmatic trial suggests best cardioprotective agents for type 2 diabetes

07-28-2023 | Type 2 diabetes | News

Better QoL after gastric bypass than sleeve gastrectomy for people with type 2 diabetes

07-20-2023 | Type 2 diabetes | News

Triple agonist shows promise for both glycemic and weight control

07-14-2023 | Type 2 diabetes | News

Cagrilintide plus semaglutide shows dual benefit in type 2 diabetes

The SURPASS trials

Get the latest reporting, researcher interviews, and independent commentary on tirzepatide for type 2 diabetes.

07-07-2023 | Type 2 diabetes | News

New atherothrombotic risk score for type 2 diabetes

07-03-2023 | Type 2 diabetes | News

‘Substantial’ bodyweight reductions with tirzepatide in people with type 2 diabetes and obesity

06-22-2023 | Cardiovascular outcomes | News

Finerenone modifies CKD-associated CV risk in albuminuric type 2 diabetes

06-05-2023 | Prediabetes | News

Caloric restriction outperforms liraglutide for weight loss in prediabetes

Semaglutide for weight loss: The STEP and SELECT trials

Get the latest results and insights from the researchers.
Image Credits